BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, December 15, 2025
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 5, 2003
View Archived Issues
European Institutes Stepping In To Add Value To Technologies
Read More
To-Do List For European Biotech: Harmonize, Get Drugs, Go Global
Read More
Correction
Read More
AVI Adds $15M To Balance Sheet Through Direct Equity Placement
Read More
Genzyme Prices Placement Of $600M In Convertible Notes
Read More
Other News To Note
Read More
Merck, Actelion Enter Potential $272M Deal On Renin Inhibition
In its second deal of the week, Merck & Co. Inc. tapped Swiss firm Actelion Inc. for a potential $272 million agreement to develop new classes of renin inhibitors for cardio-renal diseases. (BioWorld Today)
Read More
KAI Completes $17M Series A For Work In Protein Kinase C
Read More
